Regulations and their interpretation are subject to fast moving changes in the clinical / pharmaceutical industry therefore it is vital to be continually involved on the latest applications in in order to maintain expertise this field.
In smaller companies, where scientists, researchers, engineers and support staff are assigned to various projects may find that forming tried and tested collaborations with long established Regulatory Affairs consultants is a way of providing a workable blend of services – specialist advice and ‘hands on’ compilation of regulatory dossiers. Virtual Biotechs, who may require more supportive guidance through the regulatory process, would benefit enormously from this practice.
Some larger companies, even with internal resources, often prefer to out-source such services as:
- Support with the completion of CTAs;
- Consultancy and Strategic Development for Clinical Research;
- Due Diligence for New Product Licensing;
- Registration Strategy and Support;
- Clinical Research Product Development.
Out-sourcing benefits range from having additional resource costs only as-required, to increasing the knowledge pool, particularly in fast-moving topics such as regulations.
The above services are offered by one of the leading smaller clinical research organisations, www.PRNservices.co.uk, whose enviable reputation has been established over the past 12 years.
Posted in 
